CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...